$1.87 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 100 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 76.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | BIOHAVEN LTD | $92,511,987 | +76.0% | 3,867,558 | +0.5% | 4.95% | +122.7% | |
| Buy | ARCELLX INC | $90,059,041 | +21.9% | 2,848,167 | +18.8% | 4.82% | +54.3% | |
| KURA | Buy | KURA ONCOLOGY INC | $74,360,916 | -7.5% | 7,028,442 | +6.9% | 3.98% | +17.1% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $67,163,577 | +84.9% | 1,748,141 | +11.4% | 3.59% | +134.1% |
| INSM | Buy | INSMED INC | $65,606,947 | +31.2% | 3,109,334 | +6.0% | 3.51% | +66.1% |
| TERN | Buy | TERNS PHARMACEUTICALS INC | $48,666,056 | +19.2% | 5,561,835 | +61.3% | 2.60% | +50.8% |
| ETNB | Buy | 89BIO INC | $45,351,822 | +34.7% | 2,393,236 | +8.3% | 2.42% | +70.5% |
| LVS | New | LAS VEGAS SANDS CORP | $39,743,514 | – | 685,233 | +100.0% | 2.12% | – |
| NVDA | New | NVIDIA CORPORATION | $32,780,666 | – | 77,492 | +100.0% | 1.75% | – |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $29,787,904 | +198.4% | 3,423,897 | +0.9% | 1.59% | +277.5% |
| SQ | Buy | BLOCK INCcl a | $28,777,945 | +14.1% | 432,296 | +17.7% | 1.54% | +44.4% |
| GPN | New | GLOBAL PMTS INC | $27,702,642 | – | 281,188 | +100.0% | 1.48% | – |
| RH | New | RH | $27,418,263 | – | 83,189 | +100.0% | 1.47% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $27,359,172 | +4.1% | 5,883,693 | +3.4% | 1.46% | +31.8% |
| COGT | Buy | COGENT BIOSCIENCES INC | $26,281,165 | +33.9% | 2,219,693 | +22.0% | 1.40% | +69.5% |
| IFRX | Buy | INFLARX NV | $25,573,239 | +514.2% | 5,733,910 | +167.2% | 1.37% | +676.7% |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $23,921,169 | – | 237,031 | +100.0% | 1.28% | – |
| New | ZURA BIO LTD | $23,370,000 | – | 2,850,000 | +100.0% | 1.25% | – | |
| ACN | New | ACCENTURE PLC IRELAND | $21,632,384 | – | 70,103 | +100.0% | 1.16% | – |
| New | GENERAL ELECTRIC CO | $21,171,830 | – | 192,734 | +100.0% | 1.13% | – | |
| New | CANADIAN PACIFIC KANSAS CITY | $20,925,326 | – | 259,073 | +100.0% | 1.12% | – | |
| GS | Buy | GOLDMAN SACHS GROUP INC | $20,349,371 | +7.9% | 63,091 | +9.5% | 1.09% | +36.7% |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $18,872,307 | +27.9% | 5,718,881 | +10.5% | 1.01% | +62.0% |
| DFS | New | DISCOVER FINL SVCS | $18,819,394 | – | 161,056 | +100.0% | 1.01% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $18,310,554 | +17.5% | 2,034,506 | +2.6% | 0.98% | +48.8% |
| WFC | Buy | WELLS FARGO CO NEW | $18,075,236 | +44.0% | 423,506 | +26.1% | 0.97% | +82.3% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $17,560,598 | -18.5% | 7,167,591 | +4.1% | 0.94% | +3.1% |
| ATVI | New | ACTIVISION BLIZZARD INC | $17,465,948 | – | 207,188 | +100.0% | 0.93% | – |
| WWE | New | WORLD WRESTLING ENTMT INCcl a | $16,271,368 | – | 150,008 | +100.0% | 0.87% | – |
| CELH | New | CELSIUS HLDGS INC | $14,354,316 | – | 96,215 | +100.0% | 0.77% | – |
| JNJ | Buy | JOHNSON & JOHNSON | $13,705,056 | +59.9% | 82,800 | +49.8% | 0.73% | +102.5% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $11,096,511 | +708.3% | 108,832 | +620.7% | 0.59% | +922.4% |
| EVR | New | EVERCORE INCclass a | $8,781,193 | – | 71,051 | +100.0% | 0.47% | – |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $8,314,229 | +11.3% | 872,427 | +28.4% | 0.44% | +40.8% |
| SNY | Buy | SANOFIsponsored adr | $6,254,610 | +408.3% | 116,041 | +413.2% | 0.33% | +542.3% |
| DHR | Buy | DANAHER CORPORATION | $3,942,480 | +40.6% | 16,427 | +47.6% | 0.21% | +78.8% |
| GFL | New | GFL ENVIRONMENTAL INC | $3,855,750 | – | 99,375 | +100.0% | 0.21% | – |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $3,787,905 | +29.9% | 7,260 | +43.5% | 0.20% | +65.0% |
| NRIX | New | NURIX THERAPEUTICS INC | $2,804,792 | – | 280,760 | +100.0% | 0.15% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $2,241,170 | – | 81,143 | +100.0% | 0.12% | – |
| SYK | Buy | STRYKER CORPORATION | $1,330,192 | +57.4% | 4,360 | +47.3% | 0.07% | +97.2% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $1,049,756 | +165.1% | 3,070 | +98.1% | 0.06% | +229.4% |
| AVTR | Buy | AVANTOR INC | $785,655 | +141.3% | 38,250 | +148.4% | 0.04% | +200.0% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $693,762 | – | 6,058 | +100.0% | 0.04% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $216,959 | – | 2,300 | +100.0% | 0.01% | – |
| TECH | New | BIO-TECHNE CORP | $212,238 | – | 2,600 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-28 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.